Contribution: Industrial Research Assistance Program – Contributions to Firms
Oxy'Nov inc.
$48,735.00
ARP - Development of a medical device for oxygen therapy
FY 2018-19 · 2018-04-02
Summary
Develop a prototype, which allows the management of high intensity gas flows (5 to 100 L/min) (mixture of oxygen and air) automatically by varying the proportion of each gas based on oxygenation of patients (SpO2).
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
816729628
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2018-04-02 | 2018-19 | $48,735.00 |
| 3 | 2018-04-02 | 2018-19 | $48,735.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 133 days.
Additional Information (French)
Cet accord a été modifié 2 fois La date de fin du présent accord a été changé de 133 jours.
Agreement End Date
2019-07-26
Agreement Number
902174
Agreement Start Date
2018-04-02
Agreement Title
ARP - Development of a medical device for oxygen therapy
Agreement Title (French)
PRA - Développement d'un instrument médical pour l'oxygénothérapie
Agreement Type
Contribution
Agreement Value
$48,735.00
Amendment Date
2019-03-28
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Develop a prototype, which allows the management of high intensity gas flows (5 to 100 L/min) (mixture of oxygen and air) automatically by varying the proportion of each gas based on oxygenation of patients (SpO2).
Description (French)
Développé un prototype qui permet l'administration de hauts débits (5 à 100 L/min) de gaz (mélange d'oxygène et d'air) en faisant varier automatiquement la proportion de chaque gaz en fonction de l'oxygénation des patients (SpO2).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Louis-Saint-Laurent
Federal Riding (French)
Louis-Saint-Laurent
Federal Riding Number
24045
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
816729628
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Oxy'Nov inc.
Recipient Postal Code
G2J 0C4
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2018-2019-Q3-902174
